Animesh Gupta, PhD
About Animesh Gupta, PhD
Animesh Gupta, PhD, is a Scientist II at Generate:Biomedicines in Boston, Massachusetts, specializing in computational biology, statistics, and physics to enhance human health. With a diverse background in both wet lab and dry lab environments, he has held various research positions across prestigious institutions.
Work at Generate Biomedicines
Animesh Gupta currently serves as Scientist II at Generate Biomedicines, a position he has held since 2023. Located in Boston, Massachusetts, he contributes to the company's mission of advancing human health through innovative science and technology. His role involves leveraging his expertise in computational biology and bioinformatics to support various projects within the organization.
Education and Expertise
Animesh Gupta holds a Doctor of Philosophy (PhD) in Physics with a specialization in Quantitative Biology from UC San Diego, completed in 2020. He also earned a Bachelor of Technology (B.Tech) and Master of Technology (M.Tech) in Engineering Physics from the Indian Institute of Technology, Bombay, from 2009 to 2014. His educational background equips him with a strong foundation in both theoretical and applied sciences.
Background
Animesh Gupta has a diverse professional background that spans multiple prestigious institutions. He worked as a Postdoctoral Researcher at UC San Diego from 2020 to 2022 and served as a Graduate Student Researcher there from 2014 to 2020. Prior to his tenure at UC San Diego, he was an Undergraduate Researcher at the Indian Institute of Technology, Bombay, and participated in various research initiatives, including a brief stint at IISER Pune.
Achievements
Throughout his career, Animesh Gupta has developed skills in computational biology, statistics, and physics. His interdisciplinary experience allows him to bridge the gap between wet lab and dry lab environments. He specializes in high-throughput sequencing assays, contributing to projects that range from early-stage drug discovery to pre-clinical drug development.